CONGENICA

congenica-logo

Congenica is a biotechnology company that provides a diagnostic decision support platform. They have translated this research into the gold standard clinical genomic analytics platform, Sapientia, providing integration of human DNA sequences with deep clinical phenotyping, enabling clinicians to provide an actionable interpretation of genetic disease for patients. It was founded in 2013 and headquartered in Cambridge, Cambridgeshire.

#SimilarOrganizations #People #Financial #Event #Website #More

CONGENICA

Social Links:

Industry:
Bioinformatics Biotechnology Genetics Health Care Medical

Founded:
2012-01-01

Address:
Cambridge, Cambridgeshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.congenica.com

Total Employee:
11+

Status:
Active

Contact:
+44-1223-499-965

Email Addresses:
[email protected]

Total Funding:
82.36 M USD

Technology used in webpage:
IPv6 Facebook Sharer Cloudflare Network Error Logging Cloudflare SSL Amazon Virginia Region Amazon S3 CDN Cloudflare CDN Amazon SSL HubSpot CMS Hub Accelerated Mobile Pages


Similar Organizations

fulcrum-therapeutics-logo

Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.

genetwister-technologies-logo

Genetwister Technologies

Genetwister Technologies is a biotechnology company that focuses on molecular breeding, bioinformatics, and genetics of horticultural crops.

not_available_image

Health Potential

Health Potential is a biotech company that provides a DNA test kit that focusses on personal health.

moderna-therapeutics-logo

Moderna Therapeutics

Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.

proscia-logo

Proscia

Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.

tango-therapeutics-logo

Tango Therapeutics

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Current Employees Featured

yvonne-larkin_image

Yvonne Larkin
Yvonne Larkin Chief Organisational Development & Talent Officer @ Congenica
Chief Organisational Development & Talent Officer
2018-06-01

peter-fox_image

Peter Fox
Peter Fox Chief Technical Officer @ Congenica
Chief Technical Officer
2017-06-01

matthew-hurles_image

Matthew Hurles
Matthew Hurles Scientific Director @ Congenica
Scientific Director

alastair-kilgour_image

Alastair Kilgour
Alastair Kilgour Non Executive Director @ Congenica
Non Executive Director
2017-02-01

david-atkins_image

David Atkins
David Atkins CEO @ Congenica
CEO
2018-01-01

nick-lench_image

Nick Lench
Nick Lench Co-Founder @ Congenica
Co-Founder
2012-10-01

willem-haagmans_image

Willem Haagmans
Willem Haagmans VP Sales EMEA @ Congenica
VP Sales EMEA
2021-07-01

wendy-britten_image

Wendy Britten
Wendy Britten Chief Financial Officer @ Congenica
Chief Financial Officer
2018-08-01

alistair-johnson_image

Alistair Johnson
Alistair Johnson Chief Product Officer @ Congenica
Chief Product Officer
2017-11-01

tom-barber_image

Tom Barber
Tom Barber Chief Scientific Officer @ Congenica
Chief Scientific Officer
2022-05-01

Founder


eugene-bragin_image

Eugene Bragin

matthew-hurles_image

Matthew Hurles

nick-lench_image

Nick Lench

philip-beales_image

Philip Beales

richard-durbin_image

Richard Durbin

thomas-weaver_image

Thomas Weaver

Investors List

q-ventures_image

QVentures

QVentures investment in Series C - Congenica

parkwalk-advisors_image

Parkwalk Advisors

Parkwalk Advisors investment in Series C - Congenica

cambridge-innovation-capital_image

Cambridge Innovation Capital

Cambridge Innovation Capital investment in Series C - Congenica

ido-investment_image

IDO Investments

IDO Investments investment in Series C - Congenica

future-planet-capital_image

Future Planet Capital

Future Planet Capital investment in Series C - Congenica

legal-general_image

Legal & General

Legal & General investment in Series C - Congenica

xeraya-capital_image

Xeraya Capital

Xeraya Capital investment in Series C - Congenica

tencent_image

Tencent

Tencent investment in Series C - Congenica

downing-ventures_image

Downing Ventures

Downing Ventures investment in Series C - Congenica

puhua-capital_image

Puhua Capital

Puhua Capital investment in Series C - Congenica

Newest Events participated

precision-medicine-world-conference_event_image Participated in Precision Medicine World Conference on 2018-01-22 as exhibitor

Key Employee Changes

Date New article
2022-05-03 Congenica Appoints Dr. Tom Barber as Chief Scientific Officer

Official Site Inspections

http://www.congenica.com Semrush global rank: 4.42 M Semrush visits lastest month: 2.5 K

  • Host name: 199.60.103.89
  • IP address: 199.60.103.89
  • Location: Canada
  • Latitude: 43.6319
  • Longitude: -79.3716
  • Timezone: America/Toronto

Loading ...

More informations about "Congenica"

Leadership Team - Congenica

First joining Congenica in 2019 he closed out the $50m Series C fundraising and returned in 2023 to assist with the latest round. He started his finance career with Carlsberg, Cadbury and โ€ฆSee details»

Congenica - Crunchbase Company Profile & Funding

Congenica is a biotechnology company that provides a diagnostic decision support platform. They have translated this research into the gold standard clinical genomic analytics platform, โ€ฆSee details»

Congenica - LinkedIn

Congenica is a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale. We drive Precision Medicine and help reduce the โ€ฆSee details»

Congenica - Company Profile - Tracxn

Dec 16, 2024 Congenica has 518 competitors. Congenica - Provider of a platform for clinical genome analytics for treating patients with genetic diseases. Raised a total funding of $81.9M โ€ฆSee details»

Congenica Company Profile 2024: Valuation, Funding โ€ฆ

Congenica General Information Description. Developer of a clinical genome interpretation platform designed to identify genetic diseases in patients. The company's platform processes genomic datasets to detect mutations by โ€ฆSee details»

Congenica Ltd - VentureRadar

Congenica aims to revolutionize personalized patient care through accurate diagnoses, curation of evolving knowledgebases, and support in clinical trials and drug development. Sapientia is โ€ฆSee details»

Congenica Company Profile - Office Locations, Competitors ... - Craft

Congenica is a UK start-up company founded on pioneering research from the Wellcome Trust Sanger Institute, NHS clinicians and genetic testing laboratories. We are translating this โ€ฆSee details»

Member profile: Congenica Ltd | BIA - bioindustry.org

Congenica is a digital health technology company with the worldโ€™s leading Clinical Decision Support platform for accelerated genomic data interpretation. Congenica software enables โ€ฆSee details»

Congenica Home

Congenica was founded based on pioneering work at the Wellcome Trust Sanger Institute and the UK NHS. Our products combine state-of-the-art technology, market-leading automation and Artificial Intelligence to enable โ€ฆSee details»

Congenica - Overview, News & Similar companies | ZoomInfo.com

Congenica Announces Partnership With Avesthagen CAMBRIDGE, England--(BUSINESS WIRE)-- #lifechanginganswers--Congenica, a digital health company that enables precision โ€ฆSee details»

Congenica - Contacts, Employees, Board Members, Advisors

Congenica has 13 current employee profiles, including Chief Organisational Development & Talent Officer Yvonne Larkin. Yvonne Larkin Chief Organisational Development & Talent โ€ฆSee details»

Enabling genomic medicine - blog.congenica.com

Jul 16, 2019 Congenica was born out of pioneering research from the Wellcome Sanger Institute and the NHS. We are headquartered in Cambridge, UK, with a global footprint across the US โ€ฆSee details»

Investors - Congenica

Congenica sells mission-critical genomic analysis software and solutions to enterprise customers worldwide. Our world-leading platform is based on pioneering technology from the Wellcome โ€ฆSee details»

Our plans for the future: a video message from our CEO and

Nov 9, 2020 Furthermore, Congenica will deliver advanced capabilities including the ability to integrate with existing electronic health systems and deliver fully automated genomic data โ€ฆSee details»

From Research to Transforming Patientsโ€™ Lives - Congenica

Congenica founders celebrate a decade of life-changing answers. Ten years ago, a group of experts came together to realise a shared vision โ€“ that every patient should be afforded the โ€ฆSee details»

Why choose a professional solution for your genomic data

Nov 24, 2021 Congenica survey illustrates the severity and impact of specific challenges in clinical genomics practice, especially genomic analysis and reporting. ... Participants were โ€ฆSee details»

Our Services - Congenica

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, โ€ฆSee details»

Congenica - Recent Posts

Jun 22, 2023 Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, โ€ฆSee details»

Customer Support - Congenica

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, โ€ฆSee details»

linkstock.net © 2022. All rights reserved